Resolvin D1 ameliorates Inflammation-Mediated Blood-Brain Barrier Disruption After Subarachnoid Hemorrhage in rats by Modulating A20 and NLRP3 Inflammasome

• Κύριοι συγγραφείς: Chengcong Wei (Συγγραφέας), Shenquan Guo (Συγγραφέας), Wenchao Liu (Συγγραφέας), Fa Jin (Συγγραφέας), Boyang Wei (Συγγραφέας), Haiyan Fan (Συγγραφέας), Hengxian Su (Συγγραφέας), Jiahui Liu (Συγγραφέας), Nan Zhang (Συγγραφέας), Dazhao Fang (Συγγραφέας), Guangxu Li (Συγγραφέας), Shixing Shu (Συγγραφέας), Xifeng Li (Συγγραφέας), Xuying He (Συγγραφέας), Xin Zhang (Συγγραφέας), Chuanzhi Duan (Συγγραφέας)
• Μορφή: Βιβλίο
• Έκδοση: Frontiers Media S.A., 2021-02-01T00:00:00Z.
• Θέματα: article
• Διαθέσιμο Online: Connect to this object online.

Inflammation is typically related to dysfunction of the blood-brain barrier (BBB) that leads to early brain injury (EBI) after subarachnoid hemorrhage (SAH). Resolvin D1 (RVD1), a lipid mediator derived from docosahexaenoic acid, possesses anti-inflammatory and neuroprotective properties. This study...